Impact of Respiratory Allergy on Response to Initiation of Biotherapy in Severe Asthma in Adult Severe Asthmatic Patients Followed at Poitiers University Hospital on Biotherapy

Status

Enrolling by invitation

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT06916104

Acronym

IARBASP

Enrollment

100

Registered

2025-04-08

Start date

2024-03-01

Completion date

2025-03-31

Last updated

2025-04-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Biotherapy, Respiratory Allergy, Severe Asthma

Brief summary

The aim of this study is to take stock of the situation of adult patients with severe asthma on biotherapy, followed up at Poitiers University Hospital, and in particular to increase our knowledge of factors predictive of response to biotherapy. The main aim is to improve the management of adult severe asthma patients treated with biotherapy, according to their allergic status.

Interventions

OTHERsearch for respiratory allergies

analyses in terms of biotherapy and respiratory allergy

Study design

Observational model

COHORT

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Inclusion criteria

* Severe asthma patient on biotherapy * Age \> or = 18 years * Follow-up at Poitiers University Hospital

Exclusion criteria

* Absence of allergological assessment * Patient's refusal to participate in study

Design outcomes

Primary

Measure	Time frame
Find out whether a positive respiratory allergy test influences the efficacy of one or more biotherapies	1 year

Secondary

Measure	Time frame
analyze the allergological workup, particularly with regard to common pneumallergens	1 year
look at the response to the biotherapy used	1 year

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026